A judicious approach to autism would be to replace a “disability” or “illness” paradigm with a “diversity” perspective that takes into account both strengths and weaknesses and the idea that variation can be positive in and of itself.
AMA J Ethics. 2015;17(4):348-352. doi:
10.1001/journalofethics.2015.17.4.msoc1-1504.
In treating children with autism, physicians should reframe the common dynamic in which the family wants medication that the doctor is withholding to focus instead on the family’s and physician’s share goal—the patient’s well-being.
AMA J Ethics. 2015;17(4):299-304. doi:
10.1001/journalofethics.2015.17.4.ecas1-1504.
The neurodiversity movement challenges us to rethink autism through the lens of human diversity, valuing diversity in neurobiologic development as we would value it in gender, race, ethnicity, religion, or sexual orientation.
Discussing CAM offers an opportunity to study the development of basic medical science that refuted vitalism, homeopathy, humoral theory, miasma theory, the doctrine of signatures, and other prescientific myths that persist today.
Donna T. Chen, MD, MPH, Lois Shepherd, JD, and Daniel M. Becker, MD, MPH, MFA
When most statutes about confidential treatment of adolescents were adopted, immunization against sexually transmitted infection was not anticipated, so the statutes contain no specific inclusion of such preventive measures.
In treating children with autism, physicians should focus on involving parents in a shared decision making partnership and seeking safe, evidence-based, and medically and cost-effective treatments.
AMA J Ethics. 2015;17(4):310-317. doi:
10.1001/journalofethics.2015.17.4.ecas3-1504.
Although now discredited, the idea that mothers’ behavior is responsible for autism lives on in the social pressure that mothers feel to save their autistic children, at a cost to both the self-blaming parents and people with autism.
AMA J Ethics. 2015;17(4):353-358. doi:
10.1001/journalofethics.2015.17.4.mhst1-1504.